ストックスクリーナーアプリを入手
214.06
1.09%
2.30
Danaher Corp (DHR) 最新ニュース
Danaher Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Danaher stock after-hours at EUR 191.10: minus 2.35 percent - AD HOC NEWS
Danaher Corp Stock (DHR) Moved Down by 3.29% on Oct 1: What Investors Need To Know - TradingKey
Continuous Bioprocessing Technologies Market - GlobeNewswire Inc.
Danaher names Julie Sawyer Montgomery as president and CEO - Investing.com
Goldman Sachs raises target for Danaher stock to USD 250.00 - AD HOC NEWS
Guggenheim Raises Price Target on Danaher to $250 From $200, Keeps Buy Rating - marketscreener.com
What You Need to Know Ahead of Danaher’s Earnings Release - Yahoo Finance
Julie Sawyer Montgomery Assumes Role as Danaher President and Chief Executive Officer - Yahoo Finance
Danaher stock pre-market at EUR 196.30: plus 0.31 percent - AD HOC NEWS
Danaher Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
A voluntary NYSE withdrawal covers Danaher (NYSE: DHR) 2.100% senior notes due 2026. - Stock Titan
DHR's Growth Backed by Strong Biotechnology Unit: Can It Maintain the Pace? - Yahoo Finance
Masimo Wins Two OCTANE High Tech AwardsCompany Recognized for 'Deal of the Year' and 'Best Technology Leadership Team' - PR Newswire
Danaher stock trades at EUR 198.48 ahead of October 21 results - AD HOC NEWS
Danaher stock after-hours at EUR 198.88: minus 0.10 percent versus the Lang & Schwarz prior close - AD HOC NEWS
Leica Biosystems Completes Acquisition of StatLab to Bolster Delivery of More Precise, Timely Diagnostics for Cancer Patients - marketscreener.com
Leica Biosystems Acquires StatLab From Linden Capital And Audax Private Equity - Pulse 2.0
Danaher stock reports USD 6.26 billion Q2 revenue ahead of earnings - AD HOC NEWS
Danaher stock at USD 224.49 on September 25, 2026 - AD HOC NEWS
Gilead vs. Danaher: Which Healthcare Growth Story is More Convincing? - Yahoo Finance
Danaher Corp Agencies, 2024 - OpenSecrets
Global Therapeutic Drug Monitoring Consumables Market Forecast, 2026-2032 - GlobeNewswire Inc.
Danaher Corp Lobbyists, 2024 - OpenSecrets
Danaher Corp Lobbyists, 2022 - OpenSecrets
Danaher Corp. stock slips before the bell - AD HOC NEWS
What Does Veralto's (NYSE:VLTO) Dividend and Climate Validation Signal? - Kalkine Media
Danaher Corporation stock sets October earnings date - AD HOC NEWS
DHR|Danaher Corp|Price:227.330|Chg%:+2.840 - TradingKey
Danaher stock heads into the open after a 2.43 percent gain - AD HOC NEWS
Danaher stock ends the day 2.43 percent higher at USD 221.09 - AD HOC NEWS
Danaher (DHR) Stock Looks Reasonable On Label Free Detection Growth - Yahoo Finance
Danaher Corp. stock holds near USD 200 before October results - AD HOC NEWS
Danaher (DHR) Institutional Ownership 2026 $DHR - MarketBeat
Danaher stock rises 0.16 percent ahead of the open - AD HOC NEWS
Automated Microscopy Market Advances as AI-Powered Image Analysis Transforms Digital Pathology and Semiconductor Inspection - GlobeNewswire Inc.
Danaher stock rises 2.38 percent after the close - ad-hoc-news.de
Danaher Corp. stock outperforms competitors on strong trading day - MarketWatch
Danaher Schedules Third Quarter 2026 Earnings Conference Call - marketscreener.com
Danaher will webcast its next financial update Oct. 21 - Stock Titan
Danaher Corp. stock gains as valuation stays above fair value - AD HOC NEWS
Danaher Corp. stock gains 1.97 percent ahead of the open - AD HOC NEWS
Danaher stock ends the day 1.97 percent higher at the close - AD HOC NEWS
Danaher stock holds steady as reduced growth outlook tempers sentiment - AD HOC NEWS
Goldman Sachs Adjusts Price Target on Danaher to $250 From $210, Maintains Buy Rating - marketscreener.com
Danaher stock heads into the open after a modest loss - AD HOC NEWS
Danaher Corp. stock gains after UBS starts coverage with USD 250 target - AD HOC NEWS
Danaher stock gains after UBS starts coverage at USD 250 - AD HOC NEWS
Why Is Danaher (DHR) Drawing Fresh Attention? - Kalkine Media
Cardinal Health (NYSE:CAH) Vs Danaher Corporation (NYSE:DHR) – Here’s The One Jim Cramer Said Did Better - Yahoo Finance
A new gene-editing tool is designed to reduce off-target edits - Stock Titan
Danaher (DHR) Could Be 8% Below Fair Value Following Its Dividend Reaffirmation - Yahoo Finance
Danaher Corp (DHR) Shares Surge 3.0% -- What GF Score of 80 Tells Investors - GuruFocus
Danaher Corp. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Danaher Announces Quarterly Dividend - Yahoo Finance
Danaher Corp. stock holds near USD 200 as investors eye earnings and guidance - ad-hoc-news.de
3 Reasons DHR is Risky and 1 Stock to Buy Instead - Yahoo Finance
UBS assumes coverage on Danaher stock with buy rating, $250 target - Investing.com Nigeria
Thermo Fisher, Danaher Could Log Mid-Single-Digit Organic Revenue Growth in 2027, UBS Says - Yahoo Finance
Danaher Corp. stock gains support from UBS buy rating and July earnings beat - ad-hoc-news.de
Danaher stock heads into the open after a 0.87 percent slip - ad-hoc-news.de
Danaher Corp. stock outperforms competitors despite losses on the day - MarketWatch
0.46%
0.96%
大文字化:
|
ボリューム (24 時間):